Bayer AG And Genzyme Corporation's Leukemia Drug Appears To Stop Early Stage MS, University of Cambridge Study

LONDON (Reuters) - A drug developed to fight leukemia appears to stop multiple sclerosis in its early stages and restore lost function to patients, British researchers said on Wednesday.

Back to news